Profund Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Buy
7,972
+3,190
+67% +$135K 0.01% 932
2026
Q1
$264K Sell
4,782
-1,939
-29% -$92.3K 0.01% 835
2025
Q4
$251K Buy
+6,721
New +$273K 0.01% 1006
2019
Q1
Sell
-6,571
Closed -$211K 1233
2018
Q4
$211K Sell
6,571
-2,420
-27% -$91.3K 0.01% 1002
2018
Q3
$386K Buy
+8,991
New +$425K 0.01% 1002

Other funds holding PAHC

Profund Advisors's PAHC Position: Q2 2026 in Review

Profund Advisors increased its Phibro Animal Health (PAHC) stake by 67% in Q2 2026, buying an estimated $135K and bringing the position to 7,972 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #932.

Profund Advisors first reported a position in PAHC in Q3 2018 and has held it in 5 quarters since. The position peaked at $386K in Q3 2018. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Profund Advisors held 7,972 shares of Phibro Animal Health worth $250K as of Q2 2026.
  • Profund Advisors bought 3,190 Phibro Animal Health shares in Q2 2026, an estimated $135K.
  • Phibro Animal Health made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #932 holding.
  • Profund Advisors first reported a position in Phibro Animal Health in Q3 2018 and has held it in 5 quarters since.
  • Profund Advisors's Phibro Animal Health position peaked at $386K in Q3 2018.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.